A new database contains 520 studies investigating the carcinogenicity data of 238 pharmaceuticals across 14 ATC classifications

Panagiotis G Karamertzanis; Martina Evangelisti; Marco Daniele Parenti; Jochen Vom Brocke; Alberto Del Rio; Ingo Bichlmaier

doi:10.3389/ftox.2024.1450612

A new database contains 520 studies investigating the carcinogenicity data of 238 pharmaceuticals across 14 ATC classifications

Front Toxicol. 2024 Sep 17:6:1450612. doi: 10.3389/ftox.2024.1450612. eCollection 2024.

Authors

Panagiotis G Karamertzanis¹, Martina Evangelisti², Marco Daniele Parenti³, Jochen Vom Brocke¹, Alberto Del Rio^{2

3}, Ingo Bichlmaier¹

Affiliations

¹ European Chemicals Agency, Helsinki, Finland.
² Innovamol Srl, Modena, Italy.
³ Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR), Bologna, Italy.

No abstract available

Keywords: carcinogenicity; database; dataset; ontology; pharmaceuticals; tumorigenic potential; tumour.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was funded by ECHA under the framework contracts ECHA/2018/11 and ECHA/2021/67.